Cyprotex PLC (AIM:CRX) has acquired CeeTox, Inc.

Target Company Name:
Country:
Advisory:
Sector:
Partner:

CeeTox, Inc.
USA
Advisor to the buyer
Healthcare & Pharmaceuticals
Brown Gibbons Lang & Company

Acquisition of CeeTox, a CRO specializing in the provision of in vitro toxicological assays and screening data to the personal care, chemical, and pharma/biotech industries by Cyprotex.

Acquisition of CeeTox, a CRO specializing in the provision of in vitro toxicological assays and screening data

Advisor to the buyer :
Brown Gibbons Lang & Company

Experts who worked on this transaction

John Riddle

Managing Director & Principal at Brown Gibbons Lang & Company

Relevant transactions

Transactions

Project Amygdala

Private Equity

Sale of mental health services provider for high-acuity individuals in the UK

Advisor to the seller :
Cooper Parry Corporate Finance

Private Investors

Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors

Advisor to the seller :
RIóN

icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM

Advisor

Alpha Source Group, a portfolio company of Baird Capital, acquired by Probo Medical.

Advisor to the seller :
Brown Gibbons Lang & Company